IMMIX BIOPHARMA, INC. Adjustments to Additional Paid in Capital, Warrant Issued
IMMIX BIOPHARMA, INC. (IMMX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $74.60 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-27.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-27
- IMMIX BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-06-30 was $31.84K.
- IMMIX BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-03-31 was $42.76K.
- IMMIX BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $74.60K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2021-12-31 | $74.60K 10-K · filed 2023-03-27 | ||
| 2021-06-30 | $31.84K 10-Q · filed 2022-11-09 | $74.60K derived: sum of 2 quarters · filed 2022-11-09 | |
| 2021-03-31 | $42.76K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |